Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma
This study has been completed.
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00113633
  Purpose

To develop an educational video that will improve primary care follow-up, quality of care, and long term outcomes for asthma patients after a pediatric emergency department (ED) visit.


Condition Intervention
Asthma
Lung Diseases
Behavioral: Educational Video

MedlinePlus related topics: Asthma
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: Improving Follow-up After an Emergency Visit for Asthma

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Primary Outcome Measures:
  • Measured within 4 weeks: Follow-up with an asthma care provider

Secondary Outcome Measures:
  • Measured at Month 6: Return ED asthma visit
  • Measured at Week 4 and Month 6: Persistent asthma symptoms
  • Measured at Week 4: ED visit Controller prescription by PCP
  • Controller medication use
  • Days of school/work missed
  • Measured at Week 4 and Months 3 and 6: Peak expiratory flow
  • Quality of life

Enrollment: 440
Study Start Date: September 2003
Study Completion Date: June 2006
Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)
Detailed Description:

BACKGROUND:

Inner-city children are particularly at risk for poor asthma treatment outcomes and frequently obtain their asthma care in the ED. Prior studies have had limited success in improving primary care follow-up, quality of care, and long-term outcomes after a pediatric ED visit for asthma. Prior ED-based interventions have been designed to address barriers to follow-up with a primary care provider (PCP) such as an inability to obtain a follow-up appointment or lack of transportation. Focus groups and surveys of inner-city families have found that beliefs about the benefits of follow-up care and the role of preventive asthma medications have a strong impact on adherence to therapy.

DESIGN NARRATIVE:

This study will develop a brief educational video about the benefits of follow-up asthma care using a multi-disciplinary panel of experts at the Children's Hospital of Philadelphia and focus groups of parents of children with asthma. This educational video will then be combined into an intervention along with symptom screening and a reminder phone call that has been demonstrated to improve follow-up rates in a previous study. The combined intervention will be tested using a randomized trial design to determine its efficacy on healthcare utilization, asthma controller medication use, symptoms, and quality of life during the 6 months following an ED visit. The research is conducted as part of a research career development award.

  Eligibility

Ages Eligible for Study:   1 Year to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • At least 2 prior episodes of bronchodilator treatment
  • Lives within Philadelphia city limits
  • Discharged from ED after treatment for asthma

Exclusion Criteria:

  • Prior study enrollment
  • Parent unable to speak English
  • No telephone to be reachable for follow-up calls
  • Underlying cardiac disease
  • Any other chronic lung disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00113633

Locations
United States, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
Investigators
Study Chair: Joseph J. Zorc Children's Hospital of Philadelphia
  More Information

Study ID Numbers: 189, K23 HL74250
Study First Received: June 9, 2005
Last Updated: February 1, 2008
ClinicalTrials.gov Identifier: NCT00113633  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases
Hypersensitivity, Immediate
Emergencies
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes
Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on January 16, 2009